Treatment of Aggressive B Cell Lymphomas: Updates in 2019
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Link
https://link.springer.com/content/pdf/10.1007/s11899-020-00581-6.pdf
Reference63 articles.
1. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin’s lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin’s Lymphoma Classification Project. J Clin Oncol. 1998;16:2780–95. https://doi.org/10.1200/JCO.1998.16.8.2780.
2. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503–11. https://doi.org/10.1038/35000501.
3. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937–47. https://doi.org/10.1056/NEJMoa012914.
4. •• Schmitz R, Wright GW, Huang DW, et al. Genetics and Pathogenesis of Diffuse Large B-cell lymphoma. N Engl J Med. 2018;378:1396–407. https://doi.org/10.1056/NEJMoa1801445Potentially practice-changing genetic classification which has paved the way for a new era of “precision medicine” treatment approaches.
5. •• Chapuy B, Stewart C, Dunford AJ, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24:679–90. https://doi.org/10.1038/s41591-018-0016-8Potentially practice-changing genetic classification which has paved the way for a new era of “precision medicine” treatment approaches.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Primary breast lymphoma: A rare case report;International Journal of Surgery Case Reports;2024-09
2. Identification of Potential Therapeutic Targets for Plasmablastic Lymphoma Through Gene Expression Analysis: Insights into RAS and Wnt Signaling Pathways;Modern Pathology;2023-08
3. Understanding the differences in outcome between CART studies as second-line treatment in aggressive lymphoma;Journal of Oncology Pharmacy Practice;2022-07-03
4. Disparities in the long-term survival of adolescent and young adult diffuse large B cell lymphoma survivors;Cancer Epidemiology;2021-12
5. Quercetin as a Novel Therapeutic Approach for Lymphoma;Oxidative Medicine and Cellular Longevity;2021-08-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3